MSB 6.91% $1.47 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-63

  1. 653 Posts.
    lightbulb Created with Sketch. 128
    https://www.fda.gov/media/88907/download

    List of all 244 accelerated approvals based on a surrogate endpoint since 1992.

    If we divide it up, we should be able to hopefully find some similarities with these applications and what ours will potentially be.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.